Health Technology Assessment of Belimumab: A New Monoclonal Antibody for the Treatment of Systemic Lupus Erythematosus

Health Technology Assessment of Belimumab: A New Monoclonal Antibody for the Treatment of Systemic Lupus Erythematosus

Objective. Systemic lupus erythematosus (SLE) is treated with anti-inflammatory and immunosuppressive drugs and off-label biologics. Belimumab is the first biologic approved after 50 years as an add-on therapy for active disease. This paper summarizes a health technology assessment performed in Ital...

Full description

Bibliographic Details
Main Authors: Maria Lucia Specchia, Chiara de Waure, Maria Rosaria Gualano, Andrea Doria, Giuseppe Turchetti, Lara Pippo, Francesco Di Nardo, Silvio Capizzi, Chiara Cadeddu, Flavia Kheiraoui, Luca Iaccarino, Francesca Pierotti, Ilaria Palla, Maria Assunta Veneziano, Daniela Gliubizzi, Antonella Sferrazza, Nicola Nicolotti, Rolando Porcasi, Giuseppe La Torre, Maria Luisa Di Pietro, Walter Ricciardi
Format: Article
Language:English
Published: Hindawi Limited 2014-01-01
Series:BioMed Research International
Online Access:http://dx.doi.org/10.1155/2014/704207

Internet

http://dx.doi.org/10.1155/2014/704207

Similar Items